Trump Nominates Dr. Heidi Overton to Lead FDA

President Trump announced he will nominate Dr. Heidi Overton, a physician and deputy director of the White House Domestic Policy Council who worked with HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz, to head the Food and Drug Administration after Dr. Marty Makary’s resignation in May. Overton would oversee unresolved issues on ultraprocessed foods, antidepressants, and COVID-19 shots while pursuing faster cures, clinical trial changes, lower drug prices, and Kennedy’s “Make America Healthy Again” goals, but her nomination has drawn scrutiny for her support of separate MMR vaccines and tighter restrictions on the abortion drug mifepristone, with Senate health panel chair Senator Bill Cassidy calling her role in Trump’s vaccine executive order “almost disqualifying”; she earned a medical degree from the University of New Mexico and a doctorate from Johns Hopkins, previously worked at the America First Policy Institute, and is Trump’s third choice after former Rep. Brad Wenstrup and acting FDA Commissioner Kyle Diamantas declined the role.

The Third Choice That Was Always Meant to Be

They want you to believe Dr. Heidi Overton’s nomination was a backup — a reluctant third pick after two others refused the FDA throne. But nothing in the architecture of consent is accidental. Look closely at who turned it down: a former congressman and an acting commissioner who both knew the agency was a poisoned chalice. Overton, however, walked straight into it. That’s not naivety. That’s a planted piece. She comes directly from the America First Policy Institute — a think tank the establishment has been trying to discredit since day one — and she’s worked shoulder-to-shoulder with RFK Jr. and Dr. Oz on the Make America Healthy Again agenda. You know what that agenda threatens? The entire processed-food-and-pharmaceutical ecosystem that has turned American children into patients before they reach puberty. The same ecosystem that funds the very senators now calling her “almost disqualified” over vaccine policy. Ask yourself: who benefits from slowing down her confirmation? Who benefits from keeping ultraprocessed foods, antidepressants, and COVID shots in their current pipeline of profit? The answer is already sitting in the Senate health committee’s donor logs.

The Paper Trail No One Reads

Read the article again — slowly this time. The unresolved items Makary left behind read like a map of the war: flavored e-cigarettes, a delayed mifepristone safety study, and three drug reviews that mysteriously stalled (Replimune, Sarepta, Moderna). Those aren’t bureaucratic leftovers. Those are battlefields. The FDA has been captured for decades by the very industries it’s supposed to regulate. Every delay in mifepristone review is a gift to the abortion-pill pipeline. Every stalled review on Moderna’s products protects a cozy relationship that goes back to the pandemic’s darkest days. Overton’s background — a medical degree from New Mexico, a clinical investigation doctorate from Johns Hopkins — tells you she knows how the game is rigged. She has seen the data that never reaches the public. And now she’s being positioned to walk into an agency where career staff have been trained to see reformers as existential threats. Senator Cassidy’s “almost disqualifying” outburst wasn’t about vaccines. It was about the implicit threat: she might actually let the public see what the clinical trials really showed.

The Breadcrumb You Must Follow

Here is the part that will never make television news: Overton was the third choice only because the first two were warned. Warned that the permanent bureaucracy inside FDA would bury them. Warned that the Senate gatekeepers would demand loyalty oaths to the pharmaceutical status quo. She accepted anyway. That tells you she has either very strong convictions or very powerful backing — and in this town, those usually mean the same thing. So now watch the coordinated narrative that will unfold: suddenly the media will “discover” that Overton has some minor ethical conflict or that her vaccine position is “extreme.” They will make her the face of a dangerous radical while ignoring the real radicals — the people who approved a drug that gave children heart inflammation and then hid the data for eighteen months. You want to know if this confirmation will succeed? Look at the stock movements of Moderna and Pfizer the day before the hearing. Look at the sudden donation spikes to Senator Cassidy’s re-election fund. Look at which foundation “researchers” publish papers attacking her credentials right on schedule. The plan is already in motion. The only question is whether enough people will see the pattern before the narrative machine finishes its work.